Search clinical trials for: Placebo BI 10773 high dose

Total 3264 results

Boehringer Ingelheim
Eli Lilly and Company

Completed

Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls

Healthy | Diabetes Mellitus, Type 2

United States
Boehringer Ingelheim

Completed

A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjects

Diabetes Mellitus, Type 2

Austria, Germany, Italy
Boehringer Ingelheim

Completed

Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without Renal Hyperfiltration

Diabetes Mellitus, Type 1

Canada
Tatyana Zubkova

Completed

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Respiratory Syncytial Virus Infections

Russian Federation
Sahlgrenska University Hospital, Sweden
MetaboGen AB

Completed

Tolerability and Risk of Adverse Events With a Probiotic Supplement

Healthy Individuals

Sweden
Access Business Group
Clinical Research Laboratories

Completed

Evaluation of Skin Attributes Following Dietary Supplement Consumption

Skin Condition
University Hospital Tuebingen

Completed

Protein for Premies

Extreme Prematurity

Germany
Sean Liu

Active, not recruiting

A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

SARS-CoV-2

United States
CANbridge (Suzhou) Bio-pharma Co., Ltd.

Recruiting

Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease

Gaucher Disease, Type 1 | Gaucher Disease, Type 3

China
St. Olavs Hospital
Norwegian University of Science and Technology

Recruiting

Exercise Training as Medicine for Substance Use Disorder Patients

Substance Use Disorders

Norway
Satish R. Raj

Active, not recruiting

Water and the Gastropressor Response - Tachyphylaxis

Orthostatic Hypotension

United States
Reneo Pharma Ltd

Completed

A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders

Fatty Acid Oxidation Disorders

United States, France, Spain
Clementia Pharmaceuticals Inc.

Completed

Study to Compare the Pharmacokinetics, Safety, and Tolerability Following Administration of Palovarotene in Healthy Japanese and Non-Asian Subjects

FOP
Beijing Friendship Hospital

Unknown

Ruxolitinib as a Salvage Therapy for Hemophagocytic Lymphohistiocytosis

Hemophagocytic Lymphohistiocytosis

China
RWTH Aachen University
Heinrich-Heine University, Duesseldorf

Withdrawn

Peripheral Artery Occlusive Diseases (PAOD) Study - Clinical Assessment

Peripheral Artery Disease

Germany
Boehringer Ingelheim

Completed

Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers

Healthy
Biogen

Completed

Phase 1 Study to Evaluate the PK, Safety, Tolerability of BIIB023 in Chinese, Japanese, and Caucasian Healthy Volunteers

Healthy Volunteers

Australia, China
Boehringer Ingelheim

Completed

Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function

Hepatic Insufficiency | Healthy

Romania
Merck Sharp & Dohme LLC

Completed

Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001)

Dengue
Gyroscope Therapeutics Limited
Novartis Pharmaceuticals

Active, not recruiting

HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Dry Age-related Macular Degeneration

United States, Germany, United Kingdom, France, Spain, Australia, Poland
Emory University

Completed

Breath, Stress and Health: a Biocultural Study of Hatha Yoga Practice (Yoga)

Stress, Psychological | Stress, Physiological

India
Cancer Institute and Hospital, Chinese Academy...
Zhejiang Cancer Hospital; Sun Yat-sen University; Fudan University; West China... and other collaborators

Unknown

Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer

Lung Neoplasms | Carcinoma, Small Cell

China
University of Calgary

Completed

Fathers and Late Preterm Babies Study (FLPTB)

Premature Birth

Canada
Boehringer Ingelheim

Completed

Pharmacokinetics of Faldaprevir of Soft Capsule

Healthy

China
Heilpflanzenwohl AG

Completed

BEFORE Study, Efficacy of Refigura

Weight Loss | Overweight and Obesity | Efficacy, Self

Germany
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Shanghai Public Health Clinical Center; Beijing Simoonrecord Pharmaceutical...

Completed

A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

Tuberculosis

China
Charleston Laboratories, Inc

Completed

A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route

Pain | Nausea | Vomiting
InnoCare Pharma Inc.
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Evaluating Different Doses of Orelabrutinib in MCL

Mantle Cell Lymphoma

China
Gyroscope Therapeutics Limited
Novartis Pharmaceuticals

Active, not recruiting

EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 (EXPLORE)

Dry Age-related Macular Degeneration

United States, Germany, United Kingdom, Spain, Poland, Australia, France, Netherlands
Seoul National University Hospital
Gambro Renal Products, Inc.

Completed

Effects of HIgh Volume COntinuous REnal Replacement Therapy in Patients With Septic Acute Kidney Injury (HICORES)

Sepsis | Renal Replacement Therapy | Kidney Failure, Acute

Korea, Republic of
Lexeo Therapeutics

Recruiting

Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia

Friedreich Ataxia | Cardiomyopathy, Secondary

United States, Canada
Montana State University

Completed

Impact of Cottonseed Oil on Oxidative Stress, Inflammation, and Metabolism

Inflammation | Healthy | Metabolic Syndrome | Oxidative Stress

United States
University of Oxford

Completed

Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults (HIV-CORE 002)

HIV-1 Infections

United Kingdom
Inotrem

Active, not recruiting

Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock (ASTONISH)

Shock, Septic

Belgium, France, Spain, Denmark, Finland, Ireland
Boehringer Ingelheim

Completed

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment

Diabetes Mellitus, Type 2

Germany
Vaxart

Completed

Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)

Respiratory Syncytial Virus (RSV)

United States
AC Immune SA
National Institute on Aging (NIA); Alzheimer's Disease Cooperative Study (ADCS) and other collaborators

Completed

Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome (3-Star)

Down Syndrome

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

Hypersensitivity | Food Hypersensitivity | Hypersensitivity, Immediate | Peanut Hypersensitivity

United States
Ingredia S.A.

Completed

Investigation of Milk Peptides on Postprandial Blood Glucose Profile

Postprandial Hyperglycemia

Germany
Hocheol Kim

Completed

Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke

Ischemic Stroke

Korea, Republic of
Seoul National University Hospital
DongGuk University

Unknown

Effect of Ginseol Kg1 on Blood Pressure Lowering

Prehypertension | Hypertension, Stage I

Korea, Republic of
Boehringer Ingelheim

Completed

Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.

Healthy

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of KUC 7483 CL Tablets in Healthy Male Volunteers

Healthy
Ocugen

Recruiting

Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis (OCU400)

Retinitis Pigmentosa | Leber Congenital Amaurosis

United States
Yantai Yuhuangding Hospital

Recruiting

Clinical Study of Allergic Rhinitis Therapy by Stem Cells

Allergic Rhinitis

China
ST Pharm Co., Ltd.

Recruiting

A Clinical Trial of STP0404 in Treatment-Naïve Adults With HIV-1 Infection

HIV-1-infection

United States
Boehringer Ingelheim

Completed

BI 44370 TA in Acute Migraine Attack

Migraine Disorders

Belgium, El Salvador, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom
Boehringer Ingelheim

Completed

BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis

Psoriasis
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects

Healthy | Asthma

Germany

Search clinical trials for: Placebo BI 10773 high dose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations